Literature DB >> 22362898

Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?

Joel N Buxbaum1, Clement Tagoe, Gloria Gallo, John R Walker, Sunil Kurian, Daniel R Salomon.   

Abstract

In the human systemic amyloidoses caused by mutant or wild-type transthyretin (TTR), deposition occurs at a distance from the site of synthesis. The TTR synthesized and secreted by the hepatocyte circulates in plasma, then deposits in target tissues far from the producing cell, a pattern reproduced in mice transgenic for multiple copies of the human wild-type TTR gene. By 2 yr of age, half of the transgenic males show cardiac deposition resembling human senile systemic amyloidosis. However, as early as 3 mo of age, when there are no deposits, cardiac gene transcription differs from that of nontransgenic littermates, primarily in the expression of a large number of genes associated with inflammation and the immune response. At 24 mo, the hearts with histologically proven TTR deposits show expression of stress response genes, exuberant mitochondrial gene transcription, and increased expression of genes associated with apoptosis, relative to the hearts without TTR deposition. These 24-mo-old hearts with TTR deposits also show a decrease in transcription of inflammatory genes relative to that in the younger transgenic mice. After 2 yr of expressing large amounts of human TTR, the livers of the transgenic mice without cardiac deposition display chaperone gene expression and evidence of an activated unfolded protein response, while the livers of animals with cardiac TTR deposition display neither, showing increased transcription of interferon-responsive inflammatory genes and those encoding an antioxidant response. With time, in animals with cardiac deposition, it appears that hepatic proteostatic capacity is diminished, exposing the heart to a greater load of misfolded TTR with subsequent extracellular deposition. Hence systemic (cardiac) TTR deposition may be the direct result of the diminution in the distant chaperoning capacity of the liver related to age or long-standing exposure to misfolded TTR, or both.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362898      PMCID: PMC3360152          DOI: 10.1096/fj.11-189571

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  36 in total

1.  Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.

Authors:  Pedro Filipe Teixeira; Filipe Cerca; Sofia D Santos; Maria João Saraiva
Journal:  J Biol Chem       Date:  2006-06-02       Impact factor: 5.157

Review 2.  Endoplasmic reticulum stress and the making of a professional secretory cell.

Authors:  Eelco van Anken; Ineke Braakman
Journal:  Crit Rev Biochem Mol Biol       Date:  2005 Sep-Oct       Impact factor: 8.250

3.  An adaptable standard for protein export from the endoplasmic reticulum.

Authors:  R Luke Wiseman; Evan T Powers; Joel N Buxbaum; Jeffery W Kelly; William E Balch
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

4.  Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.

Authors:  Yo-ichi Takei; Takahisa Gono; Masahide Yazaki; Shu-ichi Ikeda; Toshihiko Ikegami; Yasuhiko Hashikura; Shin-ichi Miyagawa; Yoshinobu Hoshii
Journal:  Liver Transpl       Date:  2007-02       Impact factor: 5.799

5.  TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death.

Authors:  Nobumichi Ohoka; Satoshi Yoshii; Takayuki Hattori; Kikuo Onozaki; Hidetoshi Hayashi
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

Review 6.  Regulation of hypoxia-inducible genes by PGC-1 alpha.

Authors:  Jonathan Shoag; Zolt Arany
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-30       Impact factor: 8.311

7.  The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems.

Authors:  Sofia Duque Santos; Rui Fernandes; Maria João Saraiva
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

8.  Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts.

Authors:  Shinji Yamamoto; Henryk E Wilczek; Takashi Iwata; Marie Larsson; Henrik Gjertsen; Gunnar Söderdahl; Göran Solders; Bo-Göran Ericzon
Journal:  Transpl Int       Date:  2007-07-09       Impact factor: 3.782

9.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Regulated Ire1-dependent decay of messenger RNAs in mammalian cells.

Authors:  Julie Hollien; Jonathan H Lin; Han Li; Nicole Stevens; Peter Walter; Jonathan S Weissman
Journal:  J Cell Biol       Date:  2009-08-03       Impact factor: 10.539

View more
  28 in total

1.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

2.  The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

Authors:  Xin Wang; Francesca Cattaneo; Lisa Ryno; John Hulleman; Natàlia Reixach; Joel N Buxbaum
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

3.  Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.

Authors:  Yukio Akasaki; Natàlia Reixach; Tokio Matsuzaki; Oscar Alvarez-Garcia; Merissa Olmer; Yukihide Iwamoto; Joel N Buxbaum; Martin K Lotz
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

4.  Endoplasmic Reticulum Proteostasis Influences the Oligomeric State of an Amyloidogenic Protein Secreted from Mammalian Cells.

Authors:  John J Chen; Joseph C Genereux; Eul Hyun Suh; Vincent F Vartabedian; Bibiana Rius; Song Qu; Maria T A Dendle; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Chem Biol       Date:  2016-10-06       Impact factor: 8.116

5.  Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Authors:  Marcus V Simões; Fabio Fernandes; Fabiana G Marcondes-Braga; Philip Scheinberg; Edileide de Barros Correia; Luis Eduardo P Rohde; Fernando Bacal; Silvia Marinho Martins Alves; Sandrigo Mangini; Andréia Biolo; Luis Beck-da-Silva; Roberta Shcolnik Szor; Wilson Marques Junior; Acary Souza Bulle Oliveira; Márcia Waddington Cruz; Bruno Vaz Kerges Bueno; Ludhmila Abrahão Hajjar; Aurora Felice Castro Issa; Felix José Alvarez Ramires; Otavio Rizzi Coelho Filho; André Schmidt; Ibraim Masciarelli Francisco Pinto; Carlos Eduardo Rochitte; Marcelo Luiz Campos Vieira; Cláudio Tinoco Mesquita; Celso Dario Ramos; José Soares-Junior; Minna Moreira Dias Romano; Wilson Mathias Junior; Marcelo Iório Garcia Junior; Marcelo Westerlund Montera; Marcelo Dantas Tavares de Melo; Sandra Marques E Silva; Pedro Manoel Marques Garibaldi; Aristóteles Comte de Alencar Neto; Renato Delascio Lopes; Diane Xavier de Ávila; Denizar Viana; José Francisco Kerr Saraiva; Manoel Fernandes Canesin; Glaucia Maria Moraes de Oliveira; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

Review 6.  Reshaping endoplasmic reticulum quality control through the unfolded protein response.

Authors:  R Luke Wiseman; Jaleh S Mesgarzadeh; Linda M Hendershot
Journal:  Mol Cell       Date:  2022-04-21       Impact factor: 19.328

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Wild-type ATTR amyloidosis of the ureter in a 56-year-old woman with rheumatoid arthritis and Sjögren's syndrome.

Authors:  Koichiro Shinoda; Hirofumi Taki; Konen Obayashi; Yukio Ando; Akihiko Watanabe; Akira Komiya; Hideki Fuse; Koichi Tsuneyama; Kazuyuki Tobe
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

9.  Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Authors:  Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

Review 10.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.